Viewing Study NCT05753865



Ignite Creation Date: 2024-05-06 @ 6:41 PM
Last Modification Date: 2024-10-26 @ 2:53 PM
Study NCT ID: NCT05753865
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-03-03
First Post: 2023-02-22

Brief Title: A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection Albumin-bound
Sponsor: CSPC Ouyi Pharmaceutical Co Ltd
Organization: CSPC Ouyi Pharmaceutical Co Ltd

Study Overview

Official Title: A Multicenter Randomized Double-blind Phase ะจ Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection Albumin-bound
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main purpose of this study is to evaluate the efficacy and safety in patients with advanced breast cancer treated with SYHX2011 versus paclitaxel for injection albumin-bound
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None